Korean J Pain.  2013 Apr;26(2):160-163. 10.3344/kjp.2013.26.2.160.

Concurrence of Malignant Peripheral Nerve Sheath Tumor at the Site of Complex Regional Pain Syndrome Type 1: A Case Report

Affiliations
  • 1Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, Korea. hiitsme@snubh.org

Abstract

Malignant peripheral nerve sheath tumors (MPNSTs) are very rare sarcomas derived from various cells in the peripheral nerve sheath. Malignant peripheral nerve sheath tumors have a known association with neurofibromatosis type 1. Diagnosis of MPNSTs is difficult in patients with chronic pain, when MPNST occurs at an overlapping area of chronic pain. Therefore, the diagnosis can be missed unless clinicians pay attention to the possibility of this disease. Here in, we report a case of concurrent malignant peripheral nerve sheath tumor with complex regional pain syndrome type 1. A 44-year female patient, who was diagnosed with complex regional pain syndrome (CRPS) type 1 in her left ankle, visited our clinic because of aggravated pain. The cause of the aggravated pain was revealed as concurrent MPNST in the left common peroneal nerve territory, which overlapped the site of pain from CRPS.

Keyword

complex regional pain syndrome; nerve sheath neoplasm; neurofibromatosis

MeSH Terms

Animals
Ankle
Chronic Pain
Female
Humans
Nerve Sheath Neoplasms
Neurofibromatoses
Neurofibromatosis 1
Peripheral Nerves
Peroneal Nerve
Sarcoma

Figure

  • Fig. 1 Ultrasonographic images: short axis view (A) and long axis view (B). A mass with heterogeneous echogenicity can be found.

  • Fig. 2 Contrast enhanced T1 weighted magnetic resonance images: axial view (A) and coronal view. (B) About 3.0 × 3.1 × 5.2 cm sized mass along the common peroneal nerve, on the distal femur level, can be found.

  • Fig. 3 A 9.5 × 6.0 × 3.5 cm sized surgical specimen consisted of a solid mass measuring 4.0 × 3.5 × 3.5 cm.


Reference

1. Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM, Ilstrup DM. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer. 1986; 57:2006–2021. PMID: 3082508.
Article
2. Sordillo PP, Helson L, Hajdu SI, Magill GB, Kosloff C, Golbey RB, et al. Malignant schwannoma--clinical characteristics, survival, and response to therapy. Cancer. 1981; 47:2503–2509. PMID: 6791802.
Article
3. Ferner RE, Gutmann DH. International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer Res. 2002; 62:1573–1577. PMID: 11894862.
4. Hrehorovich PA, Franke HR, Maximin S, Caracta P. Malignant peripheral nerve sheath tumor. Radiographics. 2003; 23:790–794. PMID: 12740477.
Article
5. Perrin RG, Guha A. Malignant peripheral nerve sheath tumors. Neurosurg Clin N Am. 2004; 15:203–216. PMID: 15177319.
Article
6. Adamson DC, Cummings TJ, Friedman AH. Malignant peripheral nerve sheath tumor of the spine after radiation therapy for Hodgkin's lymphoma. Clin Neuropathol. 2004; 23:245–255. PMID: 15581029.
7. Amin A, Saifuddin A, Flanagan A, Patterson D, Lehovsky J. Radiotherapy-induced malignant peripheral nerve sheath tumor of the cauda equina. Spine. 2004; 29:E506–E509. PMID: 15507791.
Article
8. Bhattacharyya AK, Perrin R, Guha A. Peripheral nerve tumors: management strategies and molecular insights. J Neurooncol. 2004; 69:335–349. PMID: 15527099.
Article
9. Vauthey JN, Woodruff JM, Brennan MF. Extremity malignant peripheral nerve sheath tumors (neurogenic sarcomas): a 10-year experience. Ann Surg Oncol. 1995; 2:126–131. PMID: 7728565.
Article
10. Baehring JM, Betensky RA, Batchelor TT. Malignant peripheral nerve sheath tumor: the clinical spectrum and outcome of treatment. Neurology. 2003; 61:696–698. PMID: 12963767.
11. Koea JB, Leung D, Lewis JJ, Brennan MF. Histopathologic type: an independent prognostic factor in primary soft tissue sarcoma of the extremity? Ann Surg Oncol. 2003; 10:432–440. PMID: 12734093.
Article
12. Storm FK, Eilber FR, Mirra J, Morton DL. Neurofibrosarcoma. Cancer. 1980; 45:126–129. PMID: 6766081.
Article
13. Hruban RH, Shiu MH, Senie RT, Woodruff JM. Malignant peripheral nerve sheath tumors of the buttock and lower extremity. A study of 43 cases. Cancer. 1990; 66:1253–1265. PMID: 2119249.
Article
14. Anghileri M, Miceli R, Fiore M, Mariani L, Ferrari A, Mussi C, et al. Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution. Cancer. 2006; 107:1065–1074. PMID: 16881077.
15. Doorn PF, Molenaar WM, Buter J, Hoekstra HJ. Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis. Eur J Surg Oncol. 1995; 21:78–82. PMID: 7851559.
Article
16. Wanebo JE, Malik JM, VandenBerg SR, Wanebo HJ, Driesen N, Persing JA. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases. Cancer. 1993; 71:1247–1253. PMID: 8435801.
Article
17. Wong WW, Hirose T, Scheithauer BW, Schild SE, Gunderson LL. Malignant peripheral nerve sheath tumor: analysis of treatment outcome. Int J Radiat Oncol Biol Phys. 1998; 42:351–360. PMID: 9788415.
Article
18. Garg A, Gupta V, Gaikwad SB, Mishra NK, Ojha BK, Chugh M, et al. Scalp malignant peripheral nerve sheath tumor (MPNST) with bony involvement and new bone formation: case report. Clin Neurol Neurosurg. 2004; 106:340–344. PMID: 15297012.
Article
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr